XML 40 R28.htm IDEA: XBRL DOCUMENT
v3.23.3

Accrued Expenses and Other Current Liabilities (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Payables and Accruals [Abstract] |
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consist of the following:
|  | September 30, |  |  | December 31, |
|  | 2023 |  |  | 2022 |
|  | (in thousands) |
Vaxcyte-related accrual under Vaxcyte Supply Agreement |  | $ | 6,144 |  |  | $ | 4,830 |
CMO-related accrual |  |  | 7,428 |  |  |  | 3,900 |
Clinical trials-related accrual |  |  | 2,804 |  |  |  | 2,954 |
Other |  |  | 3,042 |  |  |  | 3,080 |
Total accrued expenses and other current liabilities |  | $ | 19,418 |  |  | $ | 14,764 |

X
- Definition Schedule of accrued liabilities and other liabilities disclosure, current. + References No definition available. + Details
Name: | stro_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTableTextBlock
Namespace Prefix: | stro_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration